查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1815433

2025年控制释放药物输送全球市场报告

Controlled Release Drug Delivery Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年控制释放给药市场将快速成长，到2029年将达到1,172.4亿美元，年复合成长率（CAGR）为12.8%。预测期内的成长可归因于多种因素，例如向个人化医疗的转变、为提高患者便利性而进行的技术整合、生技药品和生物仿製药的扩张、新兴地区的市场扩张以及聚合物科学的进步。预测期内的主要趋势包括可生物降解和生物相容性材料、奈米技术的进步、个人化和标靶治疗、植入式设备的进步以及创新的封装技术。

未来五年的预测成长率为12.8%，较我们先前对该市场的预测略有下降0.3%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能给製剂设计师带来重大挑战，因为它可能会增加来自德国和比利时的控制释放系统专用基质聚合物的成本，从而推迟缓释性产品的上市，并增加药物递送技术方面的支出。由于互惠关税以及不断升级的贸易摩擦和限制对全球经济和贸易的负面影响，关税的影响也可能更加广泛。

慢性病（也称为非传染性疾病 (NCD)）的盛行率不断上升，预计将成为控制释放药物输送市场扩张的主要驱动力。慢性病包括心臟病、癌症和糖尿病等疾病。这些疾病持续时间长，需要持续治疗，并且常常限制日常活动。控制释放药物传递在这些慢性病的治疗中起着至关重要的作用。有利于持续释放药物的药物传递製剂对于需要长期治疗或居住在医疗保健有限地区的患者尤其重要。例如，根据世界卫生组织 (WHO) 2022 年 9 月发布的报告，每年有 4,100 万人死于慢性病，占全球整体的 74%。约有 1700 万人在 70 岁前死于慢性病。此外，77% 的慢性病死亡发生在中低收入国家，预计这一数字将继续增加。因此，慢性病的日益普及正在推动控制释放药物输送市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球控制释放药物传递：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球控制释放药物输送市场：成长率分析
  • 全球控制释放药物输送市场表现：规模与成长，2019-2024
  • 全球控制释放药物传输市场预测：规模与成长，2024-2029年，2034年
  • 全球控制释放药物输送：总目标市场（TAM）

第六章 市场细分

  • 全球控制释放药物传输市场：依技术、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 沃斯特技术
  • 凝聚
  • 微胶囊化
  • 植入
  • 经皮
  • 定向投放
  • 其他技术
  • 全球控制释放药物传递市场：依释放机制、实际状况及预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合物基系统
  • 微储库分区控制药物传输系统
  • 回馈控制药物传输系统
  • 活化控制药物输送系统
  • 化学活化
  • 全球控制释放药物传输市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 定量喷雾吸入器
  • 注射
  • 经皮吸收贴片和眼用贴剂
  • 其他用途
  • 全球控制释放药物传输市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 个人
  • 研究
  • 其他最终用户
  • 全球控制释放药物传输市场：按 Wurster 技术细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 喷涂
  • 流体化床包衣
  • 全球控制释放药物传输市场：依凝聚类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 简单凝聚
  • 复合凝聚
  • 全球控制释放药物传输市场：按微胶囊类型细分、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合物基微胶囊
  • 脂质微胶囊化
  • 全球控制释放药物输送市场：依植入物类型植入、实际结果及预测，2019-2024 年、2024-2029 年、2034 年
  • 可生物降解植入
  • 不可生物降解的植入
  • 全球控制释放药物输送市场：按经皮给药设备（按类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 微针贴片
  • 水库系统
  • 矩阵系统
  • 全球控制释放药物输送市场：按标靶输送（按类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 奈米粒子
  • 抗体药物复合体
  • 脂质体
  • 全球控制释放药物传输市场：按技术（其他）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 渗透泵浦
  • 原位凝胶体系

第七章 区域和国家分析

  • 全球控制释放药物输送市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球控制释放药物输送市场：依国家、实际结果及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 控制释放药物输送市场：竞争格局
  • 控制释放药物输送市场：公司简介
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Alkermes plc Overview, Products and Services, Strategy and Financial Analysis
    • Coating Place Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Corium International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Depomed Inc.
  • Pfizer Inc.
  • Aradigm Corporation
  • Capsugel LLC
  • GlaxoSmithKline plc
  • Bayer Healthcare LLC
  • Collegium Pharmaceuticals Inc.
  • GE HealthCare Technologies Inc.
  • Adare Pharmaceuticals Inc.
  • Allergan plc
  • Novartis AG
  • Lonza Group AG
  • Colorcon Inc.
  • SKY Pharmaceuticals Pvt. Ltd.
  • AstraZeneca plc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年控制释放药物输送市场：提供新机会的国家
  • 2029年控制释放药物输送市场：细分领域带来新机会
  • 2029年控制释放药物输送市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r23277u

Controlled release drug delivery involves a dosage form designed to administer a medicine or medication in a specific manner, providing continuous and predictable kinetics for a predetermined duration.

The primary types of technology employed in controlled release drug delivery include the wurster technique, coacervation, microencapsulation, implants, transdermal delivery, targeted delivery, and others. The wurster technique, also known as fluid bed microencapsulation, encapsulates discrete particles in a fluidized bed using differential air flow to create cyclic movement of material. It encompasses various release mechanisms such as polymer-based systems, micro-reservoir partition-controlled drug delivery systems, feedback-regulated drug delivery systems, activation-modulated drug delivery systems, and chemically activated methods. These technologies find applications in metered dose inhalers, injectables, transdermal and ocular patches, among others. Major end-users include hospitals, clinics, individuals, research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The controlled release drug delivery market research report is one of a series of new reports from The Business Research Company that provides controlled release drug delivery market statistics, including controlled release drug delivery industry global market size, regional shares, competitors with a controlled release drug delivery market share, detailed controlled release drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the controlled release drug delivery industry. This controlled release drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The controlled release drug delivery market size has grown rapidly in recent years. It will grow from $65.44 billion in 2024 to $72.34 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to pioneering drug delivery systems, early polymer-based formulations, introduction of microencapsulation techniques, emergence of transdermal delivery, regulatory approvals, and standardization.

The controlled release drug delivery market size is expected to see rapid growth in the next few years. It will grow to $117.24 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to shift towards personalized medicine, technological integration for patient convenience, expansion of biologics and biosimilars, market expansion in developing regions, advancements in polymer science. Major trends in the forecast period include biodegradable and biocompatible materials, nanotechnology advancements, personalized medicine and targeted therapies, advances in implantable devices, innovative encapsulation techniques.

The forecast of 12.8% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for formulation scientists by increasing costs of specialized matrix polymers for controlled release systems sourced from Germany and Belgium, potentially delaying extended-release product launches and raising drug delivery technology expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases, also termed noncommunicable diseases (NCDs), is projected to act as a significant driver for the expansion of the controlled release drug delivery market. Chronic diseases, which encompass ailments such as heart disease, cancer, and diabetes, persist over extended periods, necessitating ongoing medical attention and often restricting daily activities. Controlled-release drug delivery plays a pivotal role in treating such chronic conditions. Particularly for patients requiring prolonged treatment or residing in areas with limited healthcare access, drug delivery formulations facilitating extended medication release are paramount. For instance, a September 2022 report shared by the World Health Organization (WHO) highlighted that annually, 41 million people succumb to chronic diseases, accounting for 74 percent of global fatalities. Approximately 17 million individuals lose their lives to chronic ailments before reaching the age of 70. Moreover, 77 percent of deaths attributed to chronic diseases occur in low- and middle-income countries, with anticipated future increases. Thus, the escalating prevalence of chronic diseases fuels the growth of the controlled release drug delivery market.

The rising healthcare expenditure is projected to drive the growth of the controlled release drug delivery market in the coming years. Healthcare spending encompasses all financial resources-both public and private-allocated to the healthcare sector within a specific geographic area, country, or economy during a designated time frame. Investment in controlled release drug delivery is a multifaceted endeavor that includes the entire lifecycle of a medicinal product, from initial research to post-market monitoring, aimed at enhancing treatment outcomes, patient adherence, and overall healthcare efficiency. For instance, in May 2024, the Office for National Statistics, a UK-based statistics authority, reported that healthcare expenditure in the UK was approximately £292 billion in 2023, marking a nominal increase of 5.6%. Furthermore, long-term health and social care spending experienced a real-term growth of 2.8% in 2022. Consequently, the increasing healthcare spending is driving the growth of the controlled release drug delivery market.

Technological progression stands out as a pivotal trend gaining traction within the controlled-release drug delivery market. Major enterprises operating in this sector are embracing novel technologies to fortify their market positions. For example, in March 2022, Evonik Industries AG, a Germany-based pharmaceutical company, introduced UDRATEC SoluFlow. This innovative microparticle technology is engineered to enhance the solubility of active medicinal constituents in oral medication formulations. Utilizing an emulsion-based processing technique, UDRATEC SoluFlow overcomes solubility barriers unattainable through traditional production methods. This addition to Evonik Health Care's suite of oral drug delivery system solutions complements existing offerings such as oral excipients such as EUDRAGIT functional polymers, ready-to-fill functional capsules such as EUDRACAPTM, and various technologies and services aimed at optimizing medication performance.

Leading entities within the chocolate syrup market are strategically engaging in partnership initiatives, with a focus on broadening applications in the ophthalmic field. Strategic partnerships denote a collaborative process wherein companies leverage each other's strengths and resources to achieve mutual benefits and foster success. For instance, in March 2023, Hovione, a Portugal-based contract drug manufacturing company, unveiled a collaboration with Ripple Therapeutics Inc. to expand the utilization of Ripple's Epidel technology beyond its current ophthalmic applications. This partnership marks a pivotal step in extending the Epidel platform's reach beyond ophthalmology, combining technical synergy, innovative vision, and a harmonious cultural alignment. Hovione's proficiency in regulated, sustained drug administration, coupled with their expertise in chemical synthesis and pharmaceutical manufacturing, forms a robust foundation for this collaboration. Ripple Therapeutics Inc. operates as a Canada-based pharmaceutical firm.

In November 2022, Alcon, a Switzerland-based pharmaceuticals and medical devices company, completed the acquisition of Aerie Pharmaceuticals, Inc. for an undisclosed sum. This strategic acquisition signifies an expansion of Alcon's diverse range of commercial products and development pipeline within the realm of ophthalmic pharmaceuticals. Aerie Pharmaceuticals, Inc., an esteemed US-based company specializing in the manufacture of ophthalmic solutions, further bolsters Alcon's portfolio and advancements in the ophthalmic pharmaceutical sector through this acquisition.

Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.

North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the controlled release drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The controlled release drug delivery market consists of revenues earned by entities by providing services such as mucoadhesive drug delivery, implantable drug delivery, and gastro-retentive drug delivery. The market value includes the value of related goods sold by the service provider or included within the service offering. The controlled release drug delivery market also includes sales of nebulizers, infusion pumps, and other systems used to provide controlled release drug delivery. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Controlled Release Drug Delivery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on controlled release drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for controlled release drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The controlled release drug delivery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Wurster Technique; Coacervation; Micro Encapsulation; Implants; Transdermal; Targeted Delivery; Other Technologies
  • 2) By Release Mechanism: Polymer Based Systems; Micro Reservoir Partition Controlled Drug Delivery Systems; Feedback Regulated Drug Delivery Systems; Activation-Modulated Drug Delivery Systems; Chemically Activated;
  • 3) By Application: Metered Dose Inhalers; Injectable; Transdermal And Ocular Patches; Other Applications
  • 4) By End User: Hospitals; Clinics; Personal; Research; Other End Users
  • Subsegments:
  • 1) By Wurster Technique: Spray Coating; Fluid Bed Coating
  • 2) By Coacervation: Simple Coacervation; Complex Coacervation
  • 3) By Micro Encapsulation: Polymer-Based Micro Encapsulation; Lipid-Based Micro Encapsulation
  • 4) By Implants: Biodegradable Implants; Non-Biodegradable Implants
  • 5) By Transdermal: Microneedle Patches; Reservoir Systems; Matrix Systems
  • 6) By Targeted Delivery: Nanoparticles; Antibody-Drug Conjugates; Liposomes
  • 7) By Other Technologies: Osmotic Pumps; In Situ Gelling Systems
  • Companies Mentioned: Johnson & Johnson Services Inc.; Merck & Co. Inc.; Alkermes plc; Coating Place Inc.; Corium International Inc.; Depomed Inc.; Pfizer Inc.; Aradigm Corporation; Capsugel LLC; GlaxoSmithKline plc; Bayer Healthcare LLC; Collegium Pharmaceuticals Inc.; GE HealthCare Technologies Inc.; Adare Pharmaceuticals Inc.; Allergan plc; Novartis AG; Lonza Group AG; Colorcon Inc.; SKY Pharmaceuticals Pvt. Ltd.; AstraZeneca plc; Biogen Inc.; Orbis Biosciences Inc.; Alza Corporation; MicroCHIPS Inc.; Endo International plc; Heron Therapeutics Inc.; Intellipharmaceutics International Inc.; Ipsen Biopharmaceuticals Inc.; Luye Pharma Group Ltd.; Medtronic plc; Nektar Therapeutics; Novo Nordisk A/S; Ocular Therapeutix Inc.; Pacira BioSciences Inc.; Progenity Inc.; Sanofi S.A.; Teva Pharmaceutical Industries Ltd.; Titan Pharmaceuticals Inc.; Vectura Group plc; West Pharmaceutical Services Inc.; Zosano Pharma Corporation; Zynerba Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Controlled Release Drug Delivery Market Characteristics

3. Controlled Release Drug Delivery Market Trends And Strategies

4. Controlled Release Drug Delivery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Controlled Release Drug Delivery Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Controlled Release Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Controlled Release Drug Delivery Market Growth Rate Analysis
  • 5.4. Global Controlled Release Drug Delivery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Controlled Release Drug Delivery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Controlled Release Drug Delivery Total Addressable Market (TAM)

6. Controlled Release Drug Delivery Market Segmentation

  • 6.1. Global Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wurster Technique
  • Coacervation
  • Micro Encapsulation
  • Implants
  • Transdermal
  • Targeted Delivery
  • Other Technologies
  • 6.2. Global Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymer Based Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Feedback Regulated Drug Delivery Systems
  • Activation-Modulated Drug Delivery Systems
  • Chemically Activated
  • 6.3. Global Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metered Dose Inhalers
  • Injectable
  • Transdermal and Ocular Patches
  • Other Applications
  • 6.4. Global Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Peronal
  • Research
  • Other End Users
  • 6.5. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Wurster Technique, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spray Coating
  • Fluid Bed Coating
  • 6.6. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Coacervation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Simple Coacervation
  • Complex Coacervation
  • 6.7. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Micro Encapsulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymer-Based Micro Encapsulation
  • Lipid-Based Micro Encapsulation
  • 6.8. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biodegradable Implants
  • Non-Biodegradable Implants
  • 6.9. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Transdermal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microneedle Patches
  • Reservoir Systems
  • Matrix Systems
  • 6.10. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Targeted Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nanoparticles
  • Antibody-Drug Conjugates
  • Liposomes
  • 6.11. Global Controlled Release Drug Delivery Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Osmotic Pumps
  • In Situ Gelling Systems

7. Controlled Release Drug Delivery Market Regional And Country Analysis

  • 7.1. Global Controlled Release Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Controlled Release Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Controlled Release Drug Delivery Market

  • 8.1. Asia-Pacific Controlled Release Drug Delivery Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Controlled Release Drug Delivery Market

  • 9.1. China Controlled Release Drug Delivery Market Overview
  • 9.2. China Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Controlled Release Drug Delivery Market

  • 10.1. India Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Controlled Release Drug Delivery Market

  • 11.1. Japan Controlled Release Drug Delivery Market Overview
  • 11.2. Japan Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Controlled Release Drug Delivery Market

  • 12.1. Australia Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Controlled Release Drug Delivery Market

  • 13.1. Indonesia Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Controlled Release Drug Delivery Market

  • 14.1. South Korea Controlled Release Drug Delivery Market Overview
  • 14.2. South Korea Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Controlled Release Drug Delivery Market

  • 15.1. Western Europe Controlled Release Drug Delivery Market Overview
  • 15.2. Western Europe Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Controlled Release Drug Delivery Market

  • 16.1. UK Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Controlled Release Drug Delivery Market

  • 17.1. Germany Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Controlled Release Drug Delivery Market

  • 18.1. France Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Controlled Release Drug Delivery Market

  • 19.1. Italy Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Controlled Release Drug Delivery Market

  • 20.1. Spain Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Controlled Release Drug Delivery Market

  • 21.1. Eastern Europe Controlled Release Drug Delivery Market Overview
  • 21.2. Eastern Europe Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Controlled Release Drug Delivery Market

  • 22.1. Russia Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Controlled Release Drug Delivery Market

  • 23.1. North America Controlled Release Drug Delivery Market Overview
  • 23.2. North America Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Controlled Release Drug Delivery Market

  • 24.1. USA Controlled Release Drug Delivery Market Overview
  • 24.2. USA Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Controlled Release Drug Delivery Market

  • 25.1. Canada Controlled Release Drug Delivery Market Overview
  • 25.2. Canada Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Controlled Release Drug Delivery Market

  • 26.1. South America Controlled Release Drug Delivery Market Overview
  • 26.2. South America Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Controlled Release Drug Delivery Market

  • 27.1. Brazil Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Controlled Release Drug Delivery Market

  • 28.1. Middle East Controlled Release Drug Delivery Market Overview
  • 28.2. Middle East Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Controlled Release Drug Delivery Market

  • 29.1. Africa Controlled Release Drug Delivery Market Overview
  • 29.2. Africa Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Controlled Release Drug Delivery Market Competitive Landscape And Company Profiles

  • 30.1. Controlled Release Drug Delivery Market Competitive Landscape
  • 30.2. Controlled Release Drug Delivery Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Alkermes plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Coating Place Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Corium International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Controlled Release Drug Delivery Market Other Major And Innovative Companies

  • 31.1. Depomed Inc.
  • 31.2. Pfizer Inc.
  • 31.3. Aradigm Corporation
  • 31.4. Capsugel LLC
  • 31.5. GlaxoSmithKline plc
  • 31.6. Bayer Healthcare LLC
  • 31.7. Collegium Pharmaceuticals Inc.
  • 31.8. GE HealthCare Technologies Inc.
  • 31.9. Adare Pharmaceuticals Inc.
  • 31.10. Allergan plc
  • 31.11. Novartis AG
  • 31.12. Lonza Group AG
  • 31.13. Colorcon Inc.
  • 31.14. SKY Pharmaceuticals Pvt. Ltd.
  • 31.15. AstraZeneca plc

32. Global Controlled Release Drug Delivery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Controlled Release Drug Delivery Market

34. Recent Developments In The Controlled Release Drug Delivery Market

35. Controlled Release Drug Delivery Market High Potential Countries, Segments and Strategies

  • 35.1 Controlled Release Drug Delivery Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Controlled Release Drug Delivery Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Controlled Release Drug Delivery Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer